Market Tracker

04/28 5:16pm ET

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

4.71
Delayed Data
As of Apr 28
 -0.02 / -0.42%
Today’s Change
1.62
Today|||52-Week Range
5.79
+76.40%
Year-to-Date
No recent news for Nymox Pharmaceutical Corp.

Today’s Trading

Previous close4.73
Today’s open4.80
Day’s range4.57 - 4.97
Volume264,223
Average volume (3 months)172,924
Market cap$231.3M
Dividend yield--
Data as of 3:59pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)+41.67%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-89.73%
P/E ratioNM
Price/Sales434.52
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PETXAratana Therapeutics...-0.10-1.59%
ABEOAbeona Therapeutics ...+0.05+0.89%
CEMPCempra Inc+0.45+11.69%
STMLStemline Therapeutic...-0.15-1.66%
Data as of 4:00pm ET, 04/28/2017

Financials

Last reporting dateMarch 11, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$283.6K
Annual profit (last year)-$13.1M
Net profit margin-4,622.39%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Paul Averback
Chief Financial Officer
Erik Danielsen
Corporate headquarters
Saint-Laurent, Quă©bec

Forecasts